Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple screening test at birth save thousands of children with sickle cell disease?

NCT ID NCT07719972

Not yet recruiting Diagnosis Sponsor: St. Jude Children's Research Hospital Source: ClinicalTrials.gov ↗

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This study tests whether combining point-of-care screening with community-based strategies can help identify infants with sickle cell disease early and connect them to care. Researchers will screen up to 6,750 newborns in Mozambique and track their health outcomes. The goal is to see if this approach is feasible in low-resource settings and could improve survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
point-of-care testing (POCT) for sickle cell disease
What this could lead to
If successful, this approach could enable widespread early diagnosis and life-saving treatment for sickle cell disease in low-resource settings.
What could go wrong
The study is early-stage and focused on feasibility in one country; results may not generalize to other regions or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

sickle cell disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SICKLE CELL DISEASE

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.